Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod

Enzo Biochem, Inc. (NYSE:ENZ) today announced that on May 7, 2019 it was issued U.S. Patent No. 10,278,960 entitled "Sphingosine Pathway Modulating Compounds for the Treatment of Cancers"...

ENZ : 3.23 (-0.31%)
CELG : 95.24 (-0.41%)
CELGZ : 0.66 (+6.45%)
Recent Analysis Shows Dollar General, PACCAR, Bellicum Pharmaceuticals, and Enzo Biochem Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dollar General Corporation...

ENZ : 3.23 (-0.31%)
PCAR : 67.56 (+0.75%)
DG : 121.96 (+1.09%)
BLCM : 2.36 (+2.16%)
Enzo Biochem: Fiscal 2Q Earnings Snapshot

NEW YORK (AP) _ Enzo Biochem Inc. (ENZ) on Monday reported a loss of $8.4 million in its fiscal second quarter.

ENZ : 3.23 (-0.31%)
Enzo Biochem Reports Second Fiscal Quarter and First Half 2019 Results and Reports Progress on Its Investments and Strategic Goals

Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company,today reported results for the fiscal quarter and first half ended January 31, 2019 along with providing...

ENZ : 3.23 (-0.31%)
Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2019 Results Tuesday, March 12, 2019 at 8:30 AM E.T.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2019 second quarter results Tuesday, March 12, 2019, at 8:30 AM E.T.

ENZ : 3.23 (-0.31%)

Van Meerten Stock Picks

NextEra Energy - Large Cap Pick
The Large Cap Pick of the Day is electric utility company NextEra Energy(NEE).
NEE -0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar